General Information
Revision date
2013-07-19
Product name
Bupivacaine Hydrochloride and Epinephrine Injection
CAS No.
73360-54-0
1.2.1 Relevant identified uses
Local anesthetic solution for use in peripheral nerve blocks
Emergency telephone
1-519-623-4800 (Monday-Friday 08 30 to 16 30
Icons in SDS
Company Information
company name
Novocol Pharmaceutical of Canada, Inc
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H303, H336
Hazard statements
Code
Statements
H303
May be harmful if swallowed
H336
May cause drowsiness or dizziness
Section 2
2.1 Classification of the substance or mixture
Narcotic effects, Category 3 Acute Toxicity, Category 5
2.2 Label elements
Symbol
Hazard statements
Warning H336 - May cause drowsiness or dizziness H303 - May be harmful if swallowed May cause skin and/or eye irritation Causes central nervous system effects such as drowsiness, confusion, excitability and nervousness. Acts as a depressant on the cardiovascular system. Avoid use in individuals with hypersensitivities to amide-type anesthetics. Use with caution in individuals with diabetes and/or severe hypertension. CONSULT PRODUCT INSERT FOR CLINICAL AND PHARMACOPIAL INFORMATION Signs and Symptoms of Overexposure: Drowsiness, confusion, excitability, nervousness, drop in blood pressure, fatigue, bluish discoloration of fingernails, lips, or skin, difficulties in breathing.
Prevention
P261 – Do not breathe mist/vapours/spray P271 – Use in a well-ventilated area
Response
P304+P430 – If inhaled – remove victim to fresh air and keep at rest in a position comfortable for breathing P312 – Call a POISON CENTER or doctor/physician if you feel unwell
Storage
P405 – Store locked up
Disposal
P501 – Dispose of contents/container in accordance with local/provincial/federal regulations WHMIS Regulatory Status: Not WHMIS-Controlled